Ligand validation:8U5T

VLR: 3-{2,16-dioxo-20-[(3aS,4R,6aS)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]-6,9,12-trioxa-3,15-diazaicosan-1-yl}-2-{(E)-[6-(4-methoxyphenyl)-1-methylquinolin-4(1H)-ylidene]methyl}-1,3-benzothiazol-3-ium

VLR is a Ligand Of Interest in 8U5T designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8U5T_VLR_A_105	8%	13%	0.226	0.749	2.68	1.48	10	6	0	0	70%	0.7
8U5T_VLR_B_104	2%	10%	0.372	0.747	2.94	1.55	12	4	0	0	60%	0.6
8U5T_VLR_C_103	1%	12%	0.359	0.637	2.84	1.4	12	3	0	0	67%	0.6667

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.